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Abstract
Several experimental studies have shown that carbon nanotubes (CNT) can induce respiratory effects, including
lung fibrosis. The cellular and molecular events through which these effects develop are, however, not clearly
elucidated. The purpose of the present review was to analyze the key events involved in the lung fibrotic reaction
induced by CNT and to assess their relationships. We thus address current knowledge and gaps with a view to draft
an Adverse Outcome Pathway (AOP) concerning the fibrotic potential of CNT.
As for many inhaled particles, CNT can indirectly activate fibroblasts through the release of pro-inflammatory (IL-1β)
and pro-fibrotic (PDGF and TGF-β) mediators by inflammatory cells (macrophages and epithelial cells) via the
induction of oxidative stress, inflammasome or NF-kB. We also highlight here direct effects of CNT on fibroblasts,
which appear as a new mode of toxicity relatively specific for CNT. Direct effects of CNT on fibroblasts include the
induction of fibroblast proliferation, differentiation and collagen production via ERK 1/2 or Smad signaling. We also
point out the physico-chemical properties of CNT important for their toxicity and the relationship between in vitro
and in vivo effects. This knowledge provides evidence to draft an AOP for the fibrogenic activity of CNT, which
allows developing simple in vitro models contributing to predict the CNT effects in lung fibrosis, and risk
assessment tools for regulatory decision.
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Background
Carbon nanotubes (CNT) are cylinders with a diameter
in the order of nanometers, constituted of one or several
graphene layers named single walled (SW) or multi
walled (MW) CNT, respectively. They attract wide inter-
ests because of their unique physico-chemical properties
useful for a variety of applications. In the last few years,
several studies have suggested diverse applications of
CNT in consumer and industrial products, in fields such
as electronics, structural engineering, manufacturing and
medicine. Thus, determining the health hazards of CNT
is of great importance in view of the increased potential
for human exposure within occupational, environmental,
medical and consumer environments. In particular, there
is a great focus on inhalation exposure because the
fibrous shape of CNT, similar to asbestos fibers, and
their high surface area raise serious concerns for harmful
respiratory effects [1]. Recent experimental studies have
indicated that CNT can induce respiratory toxicity, in-
cluding inflammatory and fibrotic reactions, and peri-
toneal mesothelioma in animals [2–7]. The National
Institute for Occupational Safety and Health (NIOSH)
has recommended an occupational exposure limit (REL)
of 1 μg/m3 together with other strategies for controlling
workplace exposures to CNT and for implementing a
medical surveillance program of exposed workers [8].
Table 1, 2, 3 shows that CNT can induce fibrotic lung
reactions, whatever the mode of experimental adminis-
tration (inhalation, aspiration or injection) or the animal
species used. Depending on their physicochemical char-
acteristics, the fibrogenic activity of CNT appear, how-
ever, to vary considerably, pointing out the necessity to
identify which CNT property(ies) drive(s) their hazard-
ous activities, and which mechanisms are involved. It is,
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Table 1 In vivo lung fibrotic reaction of CNT administered via inhalation
Inhalation studies





Other Species Strain Methods
1-28d SWCNT CNI 0.1–1 0.8–1.2 5 mg/m3, 5 h/d, 4d mouse C57BL/6 SSCK, SRS + [81]
whole body
1y SWCNT U 1–3 65 5 mg/m3, 5 h/d, 4d mouse C57BL/6 SSCK + [83]
whole body
2-12d MWCNT-7 HCC / / 10 mg/m3, 5 h/d mouse C57BL/6 J MTS + [84]
whole body
1 to 336d MWCNT-7 HCC 4.3 / 5 mg/m3, 5 h/d, 12d mouse C57BL/6 J SRS + [27]
whole body
17 m MWCNT-7 HCC 1–6 40–90 5 mg/m3, 5 h/d, 5d/w mouse B6C3F1 H&E ↑ [85]
whole body
90d MWCNT-7 HCC 5.5–6.2 94–98 0.2–5 mg/m3, 5 h/d, 4d rat F344 MTS ++ [86]
whole body
1d-14w MWCNT HMS 0.3–50 30–50 1–30 mg/m3, 6 h/d mouse C57BL/6 MTS ++ [87]
nose inh
90d MWCNT N 0.1–10 5–15 0.1–2.5 mg/m3, rat Wistar H&E - [88]
6 h/d, 5d/w, 13w
nose inh
90d MWCNT N 0.1–10 5–15 0.1–2.5 mg/m3 rat SH MTS, LS, GS - [89]
6 h/d, 5d/w, 13w
nd inh
nd: not determined. Duration: d: day; w: week; y: year. CNT type: AP: as prepared; COOH: carboxyl; NH2: amino; PD: purified. Source: A: Arkema (France); CNI: Carbon Nanotechnologies Inc. (Houston, TX); CT: Cheap
Tubes (Brattlebore, VT); HCC: Hodogaya Chemical Company; HMS: Helix Materials Solution (Richardson, TX); MC: Mitsui & Company (Tokio, Japan); N: Nanocyl (Sambreville, Belgium); NI: NanoIntegris (Skokie, IL); NP:
Nanotech Port (Chengdu, China); PIH: produced in-house; SA: Sigma-Aldrich (Lyon, France); SN: Shenzhen Nanoharbor (Shenzhen, China); SNP: Shenzhen Nanotech Port (Shenzhen, China); U: Unidym (Sunnyvale, CA).
Other: AD: acetone/sonication dispersed; ALD: atomic layer deposition; BSA: bovine serum albumin; cc-PEI: carboxyl converted PEI; D: dispersed; DPPC: dipalmitoylphosphatidylcholine; F: functionalized; ND: no dispersed;
PABS: polyaminobenzene sulfonic acid group; PEG: polyethylene glycol; PEI: polyethyleneimine; PF108-C: cruder stock; PF108-HD: homogeneously dispersed; SD: survanta dispersed; swNH2: sidewall amine. Methods: GS:
Gomori staining; H&E: Hematoxylin and eosin stain; hcIll: histopathology collagen type III; LS: Ladewig staining; MTS: Masson's trichrome staining; OH-p: hydroxyl proline, SRS: Sirius red staining; SSCK: Sircol Soluble Collagen;
WBc: western blot collagen. Fibrosis: +p < 0.05, ++p < 0.01, +++p < 0.001 as reported in the respective paper; (#) p < 0.05 difference between particle responses as reported in the respective paper; ↑: increase of fibrosis











Table 2 In vivo lung fibrotic reaction of CNT administered via intratracheal injection
Intratracheal injection studies





Other Species Strain Methods
7-56d short SWCNT SN 0.35–0.7 10–20 60 μg Mouse C57BL/6 J SSCK, MTS - [65]
long SWCNT 5–15 10–20 (3 mg/kg) +
14d SWCNT AMIDE / 0.7–1 4–6 F 10 mg/kg Mouse C57BL/6 MTS, hcI, hcIII, hα-SMA ++ [90]
SWCNT COOH 0.5–1.5 4–5 F ++
SWCNT PABS 0.5-1 1.1 F ++
SWCNT PEG 0.5–0.6 4.5 F ++
1-180d MWCNT SA 0.5–2 20–50 BSA disp 1–100 μg Rat Sprague–Dawley SSCK, MTS - [91]
(5–500 μg/kg)
1-91d MWCNT-7 MC 5 88 40–160 μg Rat F344 MTS ↑ [92]
(0.2–0.8 mg/kg)
1-30d short MWCNT NP 0.5–2 50 0.6 mg Rat SH SRS, hcIII - [15]
long MWCNT 20–50 50 (3 mg/kg) ++
60d MWCNT PIH 5.9 9.7 0.5–5 mg Rat Sprague–Dawley OH-p, MTS, ELISAc +++ [2]
MWCNTg 0.7 11.3 (2.5–25 mg/kg) ++
60d MWCNTg PIH 0.7 20–50 defects +++ 2 mg Rat Wistar OH-p, MTS ++ [93]
MWCNTg 600 defects ++ (10 mg/kg) +++
MWCNTg 2400 defects + +++
nd: not determined. Duration: d: day; w: week; y: year. CNT type: AP: as prepared; COOH: carboxyl; NH2: amino; PD: purified. Source: A: Arkema (France); CNI: Carbon Nanotechnologies Inc. (Houston, TX); CT: Cheap
Tubes (Brattlebore, VT); HCC: Hodogaya Chemical Company; HMS: Helix Materials Solution (Richardson, TX); MC: Mitsui & Company (Tokio, Japan); N: Nanocyl (Sambreville, Belgium); NI: NanoIntegris (Skokie, IL); NP:
Nanotech Port (Chengdu, China); PIH: produced in-house; SA: Sigma-Aldrich (Lyon, France); SN: Shenzhen Nanoharbor (Shenzhen, China); SNP: Shenzhen Nanotech Port (Shenzhen, China); U: Unidym (Sunnyvale, CA).
Other: AD: acetone/sonication dispersed; ALD: atomic layer deposition; BSA: bovine serum albumin; cc-PEI: carboxyl converted PEI; D: dispersed; DPPC: dipalmitoylphosphatidylcholine; F: functionalized; ND: no dispersed;
PABS: polyaminobenzene sulfonic acid group; PEG: polyethylene glycol; PEI: polyethyleneimine; PF108-C: cruder stock; PF108-HD: homogeneously dispersed; SD: survanta dispersed; swNH2: sidewall amine. Methods: GS:
Gomori staining; H&E: Hematoxylin and eosin stain; hcIll: histopathology collagen type III; LS: Ladewig staining; MTS: Masson's trichrome staining; OH-p: hydroxyl proline, SRS: Sirius red staining; SSCK: Sircol Soluble Collagen;
WBc: western blot collagen. Fibrosis: +p < 0.05, ++p < 0.01, +++p < 0.001 as reported in the respective paper; (#) p < 0.05 difference between particle responses as reported in the respective paper; ↑: increase of fibrosis











Table 3 in vivo lung fibrotic reaction of CNT administered via pharyngeal aspiration
Pharyngeal aspiration studies





Other Species Strain Methods
2w SD SWCNT CNI 0.1–1 0.8–1.2 survanta acetone disp 10 μg mouse C57BL/6 J SSCK, WBc + [29]
AD SWCNT (0.5 mg/kg) +
1-28d SWCNT CNI 0.1–1 0.8–1.2 5–20 μg mouse C57BL/6 SSCK, SRS ↑ [81]
(0.25–1 mg/kg)
1-60d SWCNT CNI / 1–4 10–40 μg mouse C57BL/6 SRS, MTS + [38]
(0.5–2 mg/kg)
28d SWCNT CNI / 1–4 40 μg mouse C57BL/6 SSCK + [17]
(2 mg/kg) C57BL/6gp91phox−/− -
28d SWCNT CNI 0.7 1–4 40 μg mouse C57BL/6 SRS, SSCK + [94]
(2 mg/kg) B6.129X1-MPO + (#)
3w SWCNT CNI 0.5–2 0.4–1.2 40 μg mouse C57BL/6 SSCK, MTS + [95]
twice a week 3 weeks
7d SWCNT CNI 1–3 1–4 40–80 μg mouse C57BL/6 SSCK + [96]
(2–4 mg/kg)
28d SWCNT U 1–3 1–4 40 μg mouse C57BL/6 SRS, SSCK + [19]
(2 mg/kg)
1y SWCNT U 1–3 65 40 μg mouse C57BL/6 SSCK + [83]
(2 mg/kg)
21d SWCNT BSA-AP-Hipco NI 1000–5000 0.7–1.1 BSA-coated 2 mg/kg mouse C57BL/6 SSCK, MTS + [47]
SWCNT PF108-Hipco 500–1500 0.7–1.1 PF-108-coated -
14-56d SWCNT / 5–15 <2 80 μg/m mouse C57BL/6 OH-p, MTS + [64]
(4 mg/kg)
90d Short SWCNT CT 1 11 40 μg/m mouse C57BL/6 J SSCK, SRS + [31]
Long SWCNT 13 11 (2 mg/kg) + (#)












Table 3 in vivo lung fibrotic reaction of CNT administered via pharyngeal aspiration (Continued)
21d MWCNT AP CT 0.57 F +
MWCNT NH2 From AP 0.45 F +
MWCNT sw-NH2 From AP 0.58 F +
MWCNT PEI From AP 0.33 / F 2 mg/kg mouse C57BL/6 SSCK, MTS + (#) [45]
MWCNT cc-PEI From AP - F +
MWCNT COOH From AP 0.38 F -
MWCNT PEG From AP 0.27 -
21d AP MWCNT D CT BSA + DPPC +
AP MWCNT ND CT / -
PD MWCNT D From AP 10–30 20–30 BSA + DPPC 2 mg/kg mouse C57BL/6 MTS, SSCK + [36]
PD MWCNT ND From AP / -
COOH MWCNT D From AP BSA + DPPC +
COOH MWCNT ND From AP / -
21d AP MWCNT CT 1.97 BSA-dispersed +
AP MWCNT CT 1.16 PF108-C -
AP MWCNT CT 0.15 PF108-HD -
PD MWCNT From AP 2.11 BSA-dispersed +
PD MWCNT From AP 1.52 20–30 PF108-C 2 mg/kg mouse C57BL/6 SSCK, MTS - [97]
PD MWCNT From AP 0.14 PF108-HD -
COOH MWCNT From AP 1.96 BSA-dispersed +
COOH MWCNT From AP 1.8 PF108-C -
COOH MWCNT From AP 0.15 PF108-HD -
1-14d MWCNT-7 MC 3.9 49 5–40 μg mouse C57BL/6 J MTS, SRS +++ [37]
(0.25–2 mg/kg)
1-56d MWCNT-7 MC 3.86 49 10–80 μg mouse C57BL/6 J SRS + [26]
(0.5–4 mg/kg)
1-56d MWCNT-7 MC 3.86 49 10–80 μg/m mouse C57BL/6 J SRS + [82]
(0.5–4 mg/kg)
1 to 56d MWCNT-7 HCC 4.3 / 80 μg/m mouse C57BL/6 J SRS + [27]
(4 mg/kg)












Table 3 in vivo lung fibrotic reaction of CNT administered via pharyngeal aspiration (Continued)
60d MWCNT NM400 N 0.7–3 5–35 +++
MWCNT NM402 A 0.7–4 6–20 12.5–100 μg/m mouse C57B6/6 OH-p, SRS +++ [23]
MWCNT NM400c N 0.1–0.5 18–35 (0.6–5 mg/kg) -
MWCNTg 2400 PIH 0.7 20–50 -
60d MWCNT NM400 N 0.7–3 5–35 ++
MWCNT long CT 10–30 11–59 100 μg/m mouse C57BL/6 OH-p, SRS ++ [34]
MWCNT short CT 0.5–2 10–47 (5 mg/kg) -
MWCNT thick CT 10–30 15–74 -
nd: not determined. Duration: d: day; w: week; y: year. CNT type: AP: as prepared; COOH: carboxyl; NH2: amino; PD: purified. Source: A: Arkema (France); CNI: Carbon Nanotechnologies Inc. (Houston, TX); CT: Cheap
Tubes (Brattlebore, VT); HCC: Hodogaya Chemical Company; HMS: Helix Materials Solution (Richardson, TX); MC: Mitsui & Company (Tokio, Japan); N: Nanocyl (Sambreville, Belgium); NI: NanoIntegris (Skokie, IL); NP:
Nanotech Port (Chengdu, China); PIH: produced in-house; SA: Sigma-Aldrich (Lyon, France); SN: Shenzhen Nanoharbor (Shenzhen, China); SNP: Shenzhen Nanotech Port (Shenzhen, China); U: Unidym (Sunnyvale, CA).
Other: AD: acetone/sonication dispersed; ALD: atomic layer deposition; BSA: bovine serum albumin; cc-PEI: carboxyl converted PEI; D: dispersed; DPPC: dipalmitoylphosphatidylcholine; F: functionalized; ND: no dispersed;
PABS: polyaminobenzene sulfonic acid group; PEG: polyethylene glycol; PEI: polyethyleneimine; PF108-C: cruder stock; PF108-HD: homogeneously dispersed; SD: survanta dispersed; swNH2: sidewall amine. Methods: GS:
Gomori staining; H&E: Hematoxylin and eosin stain; hcIll: histopathology collagen type III; LS: Ladewig staining; MTS: Masson's trichrome staining; OH-p: hydroxyl proline, SRS: Sirius red staining; SSCK: Sircol Soluble Collagen;
WBc: western blot collagen. Fibrosis: +p < 0.05, ++p < 0.01, +++p < 0.001 as reported in the respective paper; (#) p < 0.05 difference between particle responses as reported in the respective paper; ↑: increase of fibrosis











therefore, important to study and investigate how CNT
can exert their pro-fibrotic activities and to initiate pre-
vention strategies to avoid the development of diseases
in humans like asbestosis.
Regulatory toxicology currently moves towards the
mode of action concept, aligned with so-called adverse
outcome pathways (AOP). AOP refers to a conceptual
structure that portrays existing knowledge concerning a
series of key events (KE) along a biological pathway from
the molecular initial event (MIE) to the adverse outcome
(AO) [9]. Organization of these data in an AOP provides
a systematic and transparent knowledge that may help
elucidating and identifying the key mechanisms of tox-
icity, and the strength of their relationship, which lead
to the progression of the AO. This knowledge can guide
researchers to focus on key toxic events and assays or,
where data gaps exist, this might provide an incentive to
identify and highlight new mechanisms of action. Add-
itionally, AOPs can facilitate the development of simple
and fast test methods to predict the potential hazard of
CNT, thus reducing the use and costs of animal and
time-consuming experiments. The present review fo-
cuses on mechanisms of the lung fibrotic reaction
induced by CNT with a view to developing an AOP.
Lung fibrotic reactions and CNT
In response to prolonged tissue injury or chronic inflam-
mation, fibroblasts can be activated, resulting in three KE
involved in the development of lung fibrosis: i) cell pro-
liferation, ii) differentiation into myofibroblasts and iii)
exaggerated production of extracellular matrix (ECM)
proteins, leading to ECM accumulation in the lung paren-
chyma, modification of the lung architecture, organ dys-
function and, eventually, severe respiratory insufficiency
[10]. Fibroblasts can derive from different sources, includ-
ing lung resident fibroblasts, epithelial cells undergoing
epithelial-mesenchymal transition (EMT) and bone mar-
row progenitors called fibrocytes. Numerous studies have
Fig. 1 Direct effects of CNT on fibroblasts
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aimed at identifying how CNT can promote pro-fibrotic
responses, based on the current paradigm in particle toxi-
cology that considers particle-inflammation as key player
in inducing fibrosis [11, 12].
CNT can induce the release of pro-inflammatory and
pro-fibrotic growth factors by macrophages and epithe-
lial cells [13–16], which are in the frontline in lung
alveoli. The release of these mediators can induce the re-
cruitment, proliferation and differentiation of fibroblasts,
which then produce the ECM components. In this con-
text, interstitial fibroblasts, epithelial cells undergoing
EMT and fibrocytes can be involved. Additionally, other
cell types seem to be involved in fibrogenic responses
induced by CNT, such as T and B cells, polymorpho-
nuclear neutrophils (PMN), mast and endothelial cells
[17–21]. However, there is no evidence on how these
cells can activate fibroblasts upon CNT exposure and
lead to fibrosis.
In addition, scientists recently started to scrutinize the
potential interaction of CNT with fibroblasts. CNT can
activate fibroblasts in vitro, resulting in increased prolif-
eration, differentiation and collagen production [22–24].
Interestingly, only fiber-shape particles such as asbestos
[25] and CNT seem to have the capacity to induce fibro-
blast activation, suggesting a new mechanism of action
for these particles.
After reviewing recent advances in this area we
propose an AOP, focusing on CNT and lung fibrosis. In
agreement with the observations reported above, we
classified the effects of CNT in two different ways: i) dir-
ect effects on fibroblasts and ii) pro-inflammatory and
pro-fibrotic effects on macrophages and epithelial cells,
which we call “indirect” effects on fibroblasts. For the in-
direct effect on fibroblasts, we focused on macrophages
and epithelial cells, because of their central role and ex-
tensive literature published in this area. To have a clear
overview of the pathways involved in the development
of fibrosis we further structured the review in multiple
sections for each cell type analyzed (CNT localization,
effects, mechanisms, relevance of in vitro CNT activities
for in vivo effects) in order to design a structured AOP.
We summarize here evidences of a close cooperation
between fibroblasts, macrophages and epithelial cells in the
development of pulmonary fibrosis upon CNT exposure.
The direct effects of CNT on fibroblasts
Fibroblasts and CNT lung localization
To support the new paradigm that CNT can have a dir-
ect effect on fibroblasts, we first need to address the
localization of CNT deposited in the lung. Recent stud-
ies have shown the localization of CNT in the alveolar
interstitium after pharyngeal aspiration or inhalation
exposure using light microscopy, field emission elec-
tron microscopy (FESEM) and a new technique based
on enhanced-darkfield illumination optics and imaging
[26, 27]. These studies support the idea that CNT are
able to reach the alveolar interstitium rapidly after
exposure and get in close contact with fibroblasts,
suggesting that these particles can act directly on these
cells possibly contributing to fibrosis development. This
observation is further supported by a previous paper
by Mercer et al. [28], who observed that dispersed
SWCNT (average equivalent diameter 0.69 μm) reached
the deep lung and rapidly penetrated in the alveolar in-
terstitium causing after 7 days an increase of thickness
of alveolar walls and collagen content after pharyngeal
aspiration of 10 μg CNT/mouse (corresponding to
0.5 mg/kg b.w., considering a mouse weight of 20 g).
On the contrary, agglomerates and poorly dispersed
SWCNT (average equivalent diameter 15.2 μm) were
principally deposited in the proximal alveolar region
and formed granuloma, confirming that CNT aggrega-
tion plays a role in their tissue distribution and thus
fibrogenic activity. These studies used doses of CNT
equivalent to a human exposure scenario for a person
performing a light work, based on average daily CNT
workplace exposure. Also the group of Wang et al. [24]
showed that MWCNT can directly interact with fibro-
blasts in vivo. Long MWCNT (length 20–50 μm),
which were not phagocytosed by macrophages, were
found at the surface and also inside cells stained posi-
tively for FSP-1 (fibroblast specific marker) contrary to
short MWCNT (length 0.5-2 μm) after intratracheal in-
stillation of 0.6 mg/rat (3 mg/kg b.w., considering a rat
weight of 200 g). This dose is similar to that used by
Mercer et al. [28] as 80 μg CNT/mouse corresponds to
4 mg/kg b.w. Taken together, these data confirm the
relevance of investigating the direct activities of CNT
on lung fibroblasts.
CNT activities on fibroblasts
Effects
In this section, we focus on in vitro studies that ad-
dressed the activation of fibroblasts by CNT, as illus-
trated in Fig. 1. As mentioned above, the ultimate events
in fibrogenesis are fibroblast proliferation, differentiation
and ECM production. The first study that demonstrated
a direct effect of CNT on fibroblasts was published by
the group of Wang et al. [22]. Low concentrations of
dispersed SWCNT (0.02–0.24 μg/cm2), extrapolated
from in vivo doses (10–40 μg/mouse, corresponding to
0.5–2 mg/kg b.w.), stimulated cell proliferation, collagen
production and matrix metalloproteinases (MMP)-9
expression in human lung fibroblast (CRL-1490). Other
in vitro studies observed that both SWCNT and
MWCNT were able to directly stimulate fibroblast
proliferation, differentiation and collagen production
[14, 23, 24, 29–31]. In general, these studies
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demonstrated that CNT have a direct and rapid effect
on different types of fibroblasts, only after 24 or 48 h ex-
posure to doses of CNT relevant for in vivo and human
exposure scenarios. These results also show that CNT
activity on fibroblasts is not species-specific and that the
types of fibroblast tested, such as CRL-1490 and mouse
lung fibroblast (MLg), are useful cell models, providing
support to extrapolate in vitro data to in vivo and hu-
man exposures. However, some CNT have also been
observed to be cytotoxic to fibroblasts [13, 32] and it ap-
pears that this effect is related to the production of re-
active oxygen species (ROS) by fibroblasts exposed to
CNT, which we will describe in more details in the next
section. MWCNT (20 μg/ml) were also found to in-
crease transforming growth factor (TGF)-β and platelet-
derived growth factor (PDGF) mRNA and proteins in
lung fibroblasts after 24 h exposure [13]. Both growth
factors are well known as key mediators in the patho-
genesis of pulmonary fibrosis. PDGF stimulates fibro-
blast proliferation and acts as a potent chemoattractant
for fibroblasts and myofibroblasts, thereby promoting
fibrosis. TGF-β stimulates the differentiation of mesen-
chymal cells and the synthesis of collagen. Also, pro-
inflammatory mediators could mediate the release of
TGF-β and PDGF and thus potentially exacerbate
fibrosis development [13]. However, the release of pro-
inflammatory mediators by fibroblasts after CNT expos-
ure has not been observed so far.
Mechanisms
Few studies investigated the specific mechanisms of
action by which CNT can directly promote fibroblast
activation. A recent study observed that long MWCNT
(length 20–50 μm, doses 15–60 μg/ml) directly promote
fibroblast differentiation into myofibroblasts through the
activation of TGF-β/Smad signaling [24]. This pathway
is largely known to drive myofibroblast differentiation,
but explored for the first time in the context of CNT-
induced fibroblast activation. The mechanisms involved in
fibroblast proliferation were investigated in two other stud-
ies. Azad et al. [14] observed that SWCNT (5–25 μg/ml)
induce fibroblast proliferation and collagen production
through a ROS-dependent p38 MAPK signaling leading
to the production of TGF-β and vascular endothelial
growth factor (VEGF). Oxidative stress reflects an imbal-
ance between the production of different reactive metabo-
lites, including ROS and antioxidant defenses. CNT have
been shown to induce ROS production both in vitro and
in vivo, directly via physico-chemical reactivity, for ex-
ample through active residual metal catalysts present on
the surface of CNT (discussed in section: “Indirect effects
of CNT on fibroblasts”), or indirectly, via the activation of
enzymatic pathways leading to release of oxidative species.
Oxidative stress has been identified as an initiating factor
in the pathogenesis of fibrosis as it can increase pro-
fibrotic growth factors production leading to the activa-
tion of fibroblasts, as described by Azad et al. [14]. Inter-
estingly, Manke et al. [31] also observed that SWCNT
(0.06 μg/cm2) induced collagen and TGF-β production via
ROS generation in normal human lung fibroblasts
(NHLF) and these effects were inhibited in the presence
of N-acetyl cysteine (NAC). MWCNT-induced oxidative
response was also related to a cytotoxic activity of CNT
on fibroblasts [32, 33]. We showed the implication of
TGF-β, PDGF and epidermal growth factor (EGF) recep-
tors in MWCNT-induced fibroblast proliferation. In pres-
ence of low concentrations of different growth factors, we
observed that long and thin MWCNT (MWCNT length
10–30 μm and diameter 10–60 nm; doses 15 μg/cm2, cor-
responding to 24 μg/ml by considering a well surface area
of 0.32 cm2), but not short or thick CNT (MWCNT short:
length 0.5-2 μm and diameter 10–50 nm; MWCNT thick:
length 10–30 μm and diameter 15–75 nm), directly stimu-
lated fibroblast proliferation via kinase receptors, ERK 1/2
signaling and endocytosis pathways [34]. Some other stud-
ies have shown that CNT can be taken up by fibroblasts
[24]. However, for the first time it was shown that endo-
cytosis is required for the activation of fibroblasts [34].
Moreover, kinase receptors have been found to be in-
volved in the proliferative activity of MWCNT by using
receptor inhibitors, which also inhibited ERK 1/2 signaling
pathway [34]. Currently, no data is available on how CNT
could interact with these receptors. Asbestos fibers have
been shown to directly bind and activate EGF receptor
[35], suggesting that CNT could somehow interact with
kinase receptors. Azad et al. [14] and Vietti et al. [34] have
identified different mechanisms leading to CNT-induced
fibroblast proliferation. This may be related to the
physico-chemical properties of CNT, suggesting that CNT
can activate fibroblast in different ways depending on their
structure and possibly their potential to generate ROS.
However, these differences can also reflect different
experimental procedures, such as cell lines, dispersion
medium and methods used. It should be noted that the
doses able to activate fibroblasts are in the same range of
5–60 μg/ml, which has been calculated to be relevant for
in vivo and human exposure scenarios.
Relevance of in vitro CNT activities for in vivo effects
Exploring correlations between in vitro results and pul-
monary fibrotic responses in vivo is helpful to derive in
vitro assays suitable for predicting the lung fibrogenic
activity of CNT. Several studies observed a relationship
between in vitro results on fibroblasts and in vivo find-
ings [23, 30, 31, 36]. The capacity of a range of CNT to
induce fibroblast proliferation and collagen production
has been shown to correlate with their in vivo fibrotic
activity. Moreover, the upregulation of TGF-β expression
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by fibroblasts in vitro upon CNT exposure has been as-
sociated with the in vivo lung fibrosis outcome [31].
More recently, MWCNT-induced prolongation of ERK
1/2 signaling pathway in vitro was reported as a mech-
anism correlated with their activity on lung fibroblast
proliferation and, most interestingly, with their lung
fibrotic activity in vivo [34]. Taken together, these results
show that in vitro responses of lung fibroblasts to CNT
correlate to their pro-fibrogenic potential in vivo. Asses-
sing the activity of CNT in fibroblast proliferation and
collagen production assays may therefore contribute to
refine, reduce and/or replace conventional in vivo ani-
mal tests for predicting pulmonary fibrotic responses.
Indirect effects of CNT on fibroblasts
The fibrogenic activity of inhaled particles, such as as-
bestos and crystalline silica, is usually ascribed to an in-
direct effect on fibroblasts mediated by macrophages
and epithelial cells. In this section, we focus on the role
of these cells in promoting, indirectly, fibroblast activa-
tion upon CNT exposure.
The role of macrophages
Macrophages are inflammatory cells involved in innate
and adaptive immunity, present in alveoli as front line
immune defense. Their primary role is to remove or
sequester offending agents. They play an essential role in
intercellular communication through the release of
growth factors and cytokines promoting lung fibrosis
including the pro-fibrotic growth factors PDGF and
TGF-β, and pro-inflammatory cytokines, such as inter-
leukin (IL) -1β.
Macrophage recruitment and CNT phagocytosis
Traditionally, particle-induced fibrosis (asbestosis and
silicosis) has been associated with sustained inflam-
matory recruitment and responses as a first step in
fibrogenesis. Dong et al. [37] have shown a rapid infiltra-
tion of macrophages in lung tissues and alveoli after
pharyngeal aspiration of CNT (40 μg/mouse, corre-
sponding to 2 mg/kg b.w.). They observed a macrophage
infiltration at day 1 post-exposure that was maintained
till day 7 and then reduced but significantly higher than
in controls through day 14 in both the interstitial and al-
veolar spaces. The early macrophage infiltration was also
confirmed in other studies with an up-regulated number
until day 28, accompanied by an early increase of pro-
inflammatory cytokines [18, 38]. Mangum et al. [39] did
not observe an inflammatory response upon SWCNT
exposure (2 mg/kg rat b.w.) after 21 days, although inter-
stitial fibrotic lesions were observed near clusters of mac-
rophages that had engulfed aggregates of SWCNT.
However, it should be noted that lung histology may not
be sufficiently sensitive to exclude SWCNT-induced
inflammatory responses. Interestingly, the authors ob-
served that CNT were able to form intercellular structures
that bridged alveolar macrophages at 21 days post-
exposure, while these structures were not observed in the
lungs of rats exposed to carbon black (CB). Rats were ex-
posed to equivalent doses of SWCNT and CB (2 mg/kg
b.w.), with similar specific surface area (about 300–
600 m2/g), thus suggesting that the intercellular structures
that bridged alveolar macrophages were probably due to
particle shape. How CNT bridges form and their func-
tional consequences have yet to be determined. They ob-
served that a major portion of CNT was engulfed by
macrophages. Others papers have also observed the up-
take and long-term persistence of CNT within macro-
phages [2, 40]. Mercer et al. [27, 28, 40] documented the
presence of CNT within alveolar and interstitial macro-
phages and the pulmonary persistence of these particle
was associated with toxicity. However, in the study of
Kobayashi et al. [41], fibrotic responses were not observed,
though MWCNT (0.04-1 mg/kg rat b.w.) were present in
alveolar macrophages until 6 month post-exposure. Au-
thors suggested that MWCNT were being processed and
cleared by alveolar macrophages probably due to their
short length (1.5 μm). It could also be due to the lower
doses used compared to other studies (Table 1, 2, 3).
Collectively, these observations show that CNT inter-
act with macrophages. We discuss below the activities of
CNT on macrophages and their mechanisms of action
and how this may impact on fibroblast activation, thus
contributing to the indirect pro-fibrotic effects of CNT
on fibroblasts as part of the AOP.
CNT activities on macrophages
Effects Macrophages can, in response to CNT, produce
pro-inflammatory and pro-fibrotic mediators that play
important roles in inflammation and establishment of
pulmonary fibrosis. Among pro-inflammatory mediators,
IL-1β has been reported to play a key role in fibrosis
pathogenesis. MWCNT (25–100 μg/ml) were shown to
induce the release of IL-1β and IL-18 by cultured alveo-
lar macrophages isolated from naive C57BL/6 mice and
by human monocytic cell line (THP-1), and their secre-
tion was suppressed by inhibitors of caspase-1 and ca-
thepsin B [42]. Several other in vitro studies observed
that CNT enhanced IL-1β release in macrophages via
inflammasome activation, nuclear factor-kappa B (NF-kB)
and oxidative stress [13, 35, 36, 43–47], which we discuss
in the mechanisms section. Moreover, IL-1β has also been
shown to induce the release of the pro-fibrotic mediators
TGF-β and PDGF from different cell types, thus highlight-
ing the importance of the pro-inflammatory mediators
released by macrophages [13]. Tumor necrosis factor
(TNF)-α is also known to upregulate the expression of
TGF-β by epithelial cells [48]. Increased levels of TNF-α
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were observed in murine lung after CNT administration
and secreted by macrophages after in vitro exposure to
CNT [2, 38, 49, 50]. However, the role of TNF-α in CNT-
induced fibrosis is less well documented than for IL-1 β.
Both SWCNT and MWCNT have also been shown to
induce the secretion of TGF-β and PDGF from macro-
phages in vitro and in vivo [13, 15, 38, 45, 51]. Condi-
tioned media from macrophages exposed to CNT, in
which TGF-β and PDGF was measured, acted as para-
crine signals on fibroblasts by inducing their activation,
thus potentially contributing to the development of
CNT-induced lung fibrosis [13, 15]. Recent reports also
demonstrated the release of osteopontin (OPN), MMP
and tissue inhibitors of matrix metalloproteinase (TIMP)
by macrophages [50, 52]. The pro-fibrotic activity of
OPN is known to involve proliferation and migration of
fibroblasts and, like MMP and TIMP, modulation of
ECM. However, evidence for the role of OPN in CNT-
induced fibroblast activation is currently lacking.
Thus, we identified IL-1β, TGF-β and PDGF released
by macrophages as relevant paracrine signals to stimu-
late fibroblasts via alteration of several signal transduc-
tion pathways that may contribute to the AOP.
Mechanisms Recent studies have reported the role of
inflammasome activation in inducing pulmonary inflam-
mation and fibrosis. Inflammasome is a multiprotein
oligomer that mediates activation of caspase-1 which
promotes the maturation of the pro-inflammatory cyto-
kines IL-1β and IL-18. Members of the Nod-like recep-
tor family, including NLRP1, NLRP3 or NLRC4, and the
adaptor ASC are critical components of the macrophage
inflammasome. Several studies observed that CNT en-
hance IL-1β release by macrophages via inflammasome
activation [42–46].
Nuclear factor-kappa B (NF-kB), a key mediator of in-
flammatory responses, is another player implicated in
the release of IL-1β. He et al. [13] showed that MWCNT
(2–20 μg/ml) increased the secretion of different pro-
inflammatory cytokines and chemokines, such as IL-1β,
TNF-α, IL-6, IL-10 and MCP1, through the activation of
the NF-κB signaling pathway in mouse leukaemic mono-
cyte macrophage cell line (RAW 264.7). However,
authors did not provide data linking the release of pro-
inflammatory mediators with the activation of NF-kB.
Thus, it remains critical to elucidate the mechanisms by
which CNT affect NF-kB activity and the downstream
Fig. 2 Indirect effects of CNT on fibroblasts via macrophages
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responses, as the release of IL-1β. Similar observations
were obtained after THP-1 exposure to SWCNT
(0.05 mg/ml), which led to the activation of NF-kB and
the secretion of different cytokines [53].
Activation of the inflammasome and release of IL-1β have
also been associated with oxidative stress induced by CNT.
Nicotinamide adenine dinucleotide phosphate (NADPH)
oxidase is an important regulator of inflammasome and fi-
brotic development in response to CNT. NADPH oxidase
is a membrane-bound enzyme complex that generates
superoxide by transferring electrons from NADPH and
coupling these to molecular oxygen to produce superoxide
anion. NADPH oxidase is composed of transmembrane
(gp91phox and p22phox), cytosolic (p40phox, p47phox and
p67phox) and GTPase (Rac 1/2) subunits. Sun et al. [54]
observed that NADPH oxidase-induced oxidative stress
was involved in the generation of lung fibrosis upon
MWCNT exposure, via NLRP3 inflammasome activation
and IL-1β production. These responses were obtained in
wild-type and p22phox-deficient THP-1 macrophage cells,
p47phox-deficient primary bone marrow-derived macro-
phages and in vivo models (C57BL/6 and p47phox−/−
C57BL/6 mice) exposed to 50 μg/ml and 50 μg/mouse
(corresponding to 2.5 mg/kg b.w.) MWCNT, respectively.
These data were also confirmed by treating wild type mice
with NAC, a thiol antioxidant, confirming a significant re-
duction of IL-1β, TGF-β and collagen deposition in vivo.
Another study showed that long, needle-like CNT
(100 μg/ml, length of about 13 μm) induced NLRP3
inflammasome activation via ROS production [43]. Thus,
oxidative stress plays a role in the activation of the inflam-
masome by CNT and release of IL-1β, which can contrib-
ute to the induction of pro-fibrotic growth factors and
fibrosis development.
Phagocytosis of CNT has also been implicated in the
release of reactive species, mainly associated with frus-
trated phagocytosis, which is a pro-inflammatory condi-
tion [55]. This occurs when particles are physically too
long for the macrophages to engulf them. CNT which
undergo frustrated phagocytosis or were taken up by
macrophages induced oxidative stress [56, 57]. Further
studies should be conducted to investigate the direct re-
lationship between CNT phagocytosis, oxidative stress
and their impact on the release of IL-1β, for example by
using endocytosis inhibitors. Moreover, frustrated pha-
gocytosis also led to CNT biopersistence, as the clear-
ance of inhaled material is hampered, and to the release
of pro-inflammatory (IL-6 and IL-8) and pro-fibrotic
mediators (TGF-β) [58, 59]. These data suggest a rele-
vant role of oxidative stress in CNT-induced IL-1β re-
lease and fibrosis development.
In conclusion and in the context of the AOP, inflam-
masome, NF-kB and oxidative stress induced by CNT in
macrophages can be identified as important mechanisms
of action since these can induce the release of pro-
inflammatory and pro-fibrotic mediators regulating
fibroblast activation and fibrotic responses.
Relevance of in vitro CNT activities for in vivo effects
We found fewer studies that investigated the relation-
ship between the response of macrophages in vitro and
in vivo data regarding the development of lung fibrosis,
compared to the direct effect of CNT on fibroblasts.
CNT able to trigger the release of IL-1β by THP-1 or al-
veolar macrophages in vitro were observed to induce an
increase of this cytokine and collagen deposition in the
alveolar region of mice [36, 45, 47, 54]. Sun et al. [54]
observed the implication of NADPH oxidase in the acti-
vation of the NLRP3 inflammasome and the release of
IL-1β both in vitro and in vivo and thus the develop-
ment of lung fibrosis. Unfortunately, these authors have
investigated only one type of MWCNT in vivo whereas
several CNT were used in the in vitro tests. Thus, the
relevance of these in vitro data should be confirmed with
a wider range of CNT. The release of TGF-β and PDGF
has also been observed in a co-culture of THP-1 with
human bronchial epithelial cells (BEAS-2B) exposed to
CNT and associated with an increase of collagen and of
these growth factors in vivo [45].
Taken together, these results suggest that the release
of TGF-β, PDGF and IL-1β (that can also act as auto-
crine signals) by macrophages exposed to CNT can act
as paracrine signals for the activation of fibroblasts, sup-
porting an indirect mechanism of CNT to activate fibro-
blasts, as illustrated in Fig. 2. This knowledge is used for
establishing the AOP, as in vitro studies on macrophages
were identified as another potentially effective model for
assessing the pro-fibrogenic potential of CNT. To inves-
tigate the indirect effect of CNT on fibroblast via macro-
phages, TGF-β, PDGF and IL-1β are relevant mediators
and inflammasome, NF-kB and oxidative stress are rele-
vant pathways.
The role of epithelial cells
The alveolar epithelium comprises two main cell types:
type I and type II pneumocytes. Type I cell represents
the gas exchange surface in the alveolus and cover about
97 % of the total alveolar surface area, while type II cells
mainly release pulmonary surfactant to optimize condi-
tions for gas exchange. In case of tissue injury, type I
cells can be damaged, causing a loss of epithelial barrier
and type II cells can i) be activated to release inflamma-
tory mediators, ii) proliferate or differentiate in type I
cells to restore the injured basement membranes, iii)
undergo epithelial-mesenchymal transition (EMT) as an
alternative source of fibroblasts to repair injured tissue.
Also the epithelial cells in the trachea or bronchi region
have a role in the pulmonary system. These cells secrete
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mucus, which helps to maintain epithelial moisture and
traps particulate material and pathogens moving through
the airway. Several evidences show that the effect of
CNT on epithelial cells can play an important role in
fibrosis development. CNT can induce the indirect acti-
vation of fibroblasts via the release of pro-inflammatory
and pro-fibrotic mediators by epithelial cells and, add-
itionally, CNT have been found to induce the transform-
ation of epithelial cells through EMT.
Epithelial surface and CNT localisation
Alveolar epithelial cells are one of the first targets of
CNT once inhaled, and CNT were observed to directly
interact with alveolar epithelial cells in vivo few days
after particle exposure. CNT (0.6 mg/rat, corresponding
to 3 mg/kg b.w.) accumulated and were taken up by epi-
thelial cells stained positively for E-cadherin in vivo, and
these data were confirmed in vitro in a rat alveolar type
II cell line [24]. Mercer et al. [40] observed a rapid and
direct penetration of MWCNT (80 μg/mouse, corre-
sponding to 4 mg/kg b.w.) in type I epithelial cells only
one day after mice exposure. In contrast, they rarely ob-
served the penetration of MWCNT in type II epithelial
cells. However, several in vitro studies showed the cap-
acity of different type II epithelial cell lines to take up
CNT [36, 60–62].
The above data highlight that CNT are able to rapidly
enter in contact with epithelial cells, thus potentially in-
ducing a variety of adverse effects on these cells, which
can contribute to promote a fibrotic process. In the fol-
lowing sections we will discuss CNT activities on epithe-
lial cells, including the process of EMT, and release of
pro-inflammatory and pro-fibrotic mediators, and their
impact on fibroblasts. This knowledge contributes to the
development of the AOP.
CNT activities on epithelial-mesenchymal transition
Epithelial injury can lead to EMT, a process character-
ized by the transition of epithelial cells to mesenchymal
features, by which epithelial cells lose their cell polarity
and cell-cell adhesion, and gain migratory and invasive
properties. EMT has been suggested to play an import-
ant role in fibrosis development, providing an alternative
source of fibroblasts and causing a loss of epithelial bar-
rier [63].
Currently, few studies have analyzed the effect of CNT
on EMT and its effective role in fibrosis induced by
CNT is still unclear. Chang et al. [64] showed that in
vivo SWCNT exposure (80 μg/mouse, corresponding to
4 mg/kg b.w.) induced EMT of lung epithelial cells,
identified by surfactant protein C (SPC) and N-cadherin
(N-cad) markers. Moreover, these epithelial derived fi-
broblasts have been shown to produce collagen. Authors
suggested that this process was induced by the activation
of TGF-β/p-Smad2 and β-catenin in epithelial cells. Two
other studies confirmed the importance of TGF-β/Smad2
signaling in CNT-induced EMT [24, 65]. Chen et al. ex-
posed mice (60 μg/mouse, corresponding to 3 mg/kg b.w.)
and A549 cells (1.4–16 μg/cm2, corresponding to 2–
26 μg/ml considering a well surface area of 0.32 cm2) to
long (length 5–15 μm) and short (length 350–750 nm)
MWCNT. Wang et al. tested long (length 20–50 μm) and
short (0.5–2 μm) MWCNT in rats (0.6 mg/rat, corre-
sponding to 3 mg/kg b.w.) and the rat alveolar type II cell
line (RLE-6TN; 30 μg/ml). Both in vivo studies showed
that only long MWCNT, but not short fibers, directly inter-
acted with epithelial cells, were taken up by endocytosis
and promoted EMT. In vitro data confirmed that only long
MWCNT induced EMT through the activation of TGF-β/
Smad2 signaling in epithelial cells and CNT were shown to
downregulate E-cadherin and upregulate α-SMA, cell-cell
adhesion and myofibroblast markers, respectively.
In summary, CNT-induced EMT was confirmed in dif-
ferent species and in epithelial cells of various origins.
The mechanism of CNT-induced EMT is similar to that
identified for CNT-induced fibroblast differentiation,
TGF-β/Smad2 signaling playing a key role in cell trans-
formation in response to CNT. On the other hand,
asbestos was found to induce EMT in A549 cells via the
MAPK/ERK pathway, not associated with TGF-β signal-
ing activity [66]. Thus, CNT have been shown to in-
crease fibroblast population via the induction of EMT.
CNT activities on epithelial cells
Effects Activation of epithelial cells after CNT exposure
can result in the release of pro-inflammatory and pro-
fibrotic mediators. Hussain et al. [16] demonstrated that
the internalization of MWCNT (1.5–24 μg/ml) in pri-
mary human bronchial epithelial cells (HBE) induced
the release of IL-1β and IL-18, which have been
identified as key modulators of pro-fibrotic responses in
fibroblasts, including the expression of tenascin (TN)-C
(an extracellular matrix glycoprotein), TIMP-1 and
OPN. Authors also observed a release of IL-8 from epi-
thelial cells upon CNT exposure, which contributed to
the expression of TN-C by fibroblasts. Sweeney et al.
[67] observed a release of IL-8, and IL-6, upon exposure
to MWCNT (1–50 μg/ml) in a human alveolar type-I
like epithelial cell line and primary human alveolar type-
II epithelial cells, showing that both type I and II cells
can play an active role in pulmonary responses to CNT.
Several studies showed that both SWCNT (100 μg/ml)
and MWCNT (10–100 μg/ml), were able to trigger the
release of TGF-β from BEAS-2B cells [36, 47] that is
able to stimulate fibroblasts and induce EMT. In
addition, MWCNT (20 μg/ml) were found to increase
the expression and protein levels of the pro-fibrogenic
growth factor PDGF in BEAS-2B, as well as TGF-β [13].
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Another study also analyzed the impact of CNT on
ciliated tracheobronchial epithelium, as these cells play a
role in the clearance of inhaled particles by ciliary trans-
port [68]. These authors showed that MWCNT with a
length of 3 and 8 μm damaged the ciliated epithelium in
the trachea of rats (250 μg/ml in rat, corresponding to
75 μg/rat considering that rats were treated with 0.3 ml)
and mouse tracheal epithelial cells in vitro (10 μg/ml)
and suggested that these lesions can prevent the clear-
ance of inhaled CNT in the lung and thus lead to a
chronic inflammatory process. Moreover, long MWCNT
and SWCNT (100 μg/ml; length of 5–9 μm and 0.5–
100 μm, respectively) have been shown to cause an im-
pairment of airway epithelium barrier, as demonstrated
by a decrease of the trans-epithelial electrical resistance
(TEER) on human epithelial Calu-3 cells, contrary to
short CNT (length 0.5–2 μm) and CB [69]. As reported
by Snyder et al. [70], this reduction in barrier functions
can be related to the interference of MWCNT with the
cytoskeleton on lung epithelium. Further studies should
investigate the effects of CNT on epithelial barrier and
ciliated epithelium as this could have a role in CNT bio-
persistence and lung damage.
In summary, CNT stimulate the secretion of relevant
pro-fibrotic and pro-inflammatory mediators, including
TGF-β, PDGF, IL-1β and IL-8, by epithelial cells that
can indirectly promote the activation of fibroblasts and
induce EMT, two relevant sources of pulmonary fibro-
blasts. Moreover, the loss of epithelial barrier and cili-
ated epithelium can contribute to CNT biopersistence,
resulting in chronic damage and permanence of CNT in
the lung. It necessary to note that the majority of these
studies, regarding the effect of CNT on epithelial cells,
have been performed on bronchial cell type, while few au-
thors have focused on alveolar epithelial cells, which, how-
ever, represent one of the first target in CNT exposure.
Mechanisms Few studies investigated the mechanism
involved in the release of pro-inflammatory and pro-
fibrotic mediators by epithelial cells. Hussain et al. have
demonstrated that MWCNT (1.5–24 μg/ml) activated
the NLRP3 inflammasome in HBE cells and induced the
release of IL-1β and IL-18. Conditioned medium from
MWCNT-treated HBE added on human lung fibroblasts
increased the expression of OPN, TIMP-1, pro-collagen
1 and TN-C, which were decreased in the presence of
IL-1β and IL-18 antibodies and siRNA against NLRP3
inflammasome. These results point out the importance
of inflammasome activation and derived mediators in
epithelial cells to induce fibroblast activation.
The release of IL-6 and IL-8 has also been investigated
and has been found to be associated to JNK, p38 and
ERK 1/2 MAPK signaling pathways in transformed
human alveolar type-I-like epithelial cells (TT1) and pri-
mary human alveolar type-II epithelial cells (ATII) cells
upon MWCNT (50 μg/ml) exposure [67]. This result
was further confirmed by Hirano et al. [71], who ob-
served NF-κB activation, enhanced MAP kinase phos-
phorylation and increased IL-6 and IL-8 release in
BEAS-2B cells after MWCNT (2–10 μg/ml) exposure.
Fig. 3 Indirect effects of CNT on fibroblasts via epithelial cells
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Table 4 In vitro CNT activities on fibroblast, macrophage or epithelial cell
Cell CNT Concentrations Effects Mechanisms References





Fibroblast CRL1490 AP MWCNT D BSA + DPPC P
AP MWCNT ND / /
PD MWCNT D CT 10–30 20–30 BSA + DPPC 5 μg/ml P nd [30]
PD MWCNT ND / /
COOH MWCNT D BSA + DPPC /
COOH MWCNT ND / /
Fibroblast MLg, HFL-1, MWCNT NM400 N 0.7–3 5–35 7.5–30 μg/cm2 P
BALB-3 T3, MWCNT NM402 A 0.7–4 6–20 (12–48 μg/ml) P nd [23]
PMF MWCNT NM400c N 0.1–0.5 18–35 /
MWCNTg 2400 PIH 0.7 20–50 /
Fibroblast MLg MWCNT NM400 N 0.7–3 5–35 7.5–15 μg/cm2 P KR, End, Erk 1/2
MWCNT long CT 10–30 11–59 (12–24 μg/ml) P Erk 1/2 [34]
MWCNT short CT 0.5–2 10–47 /
MWCNT thick CT 10–30 15–74 /
Fibroblast NIH-3 T3 MWCNT NP 20–50 50 15–60 μg/ml P, C, D Smad [24]
Fibroblast CRL1490 SWCNT CNI 0.02–0.24 μg/cm2 P, C, MMP-9 nd [22]
(0.03–0.4 μg/ml)
Fibroblast CRL1490 SD SWCNT CNI 0.1–1 0.8–1.2 SD 0.02 μg/cm2 C
nd
[29]
AD SWCNT AD (0.03 μg/ml) C
Fibroblast CRL1490 SWCNT CNI 0.1–1 0.8–1.2 5–25 μg/ml P, C, TGF-β, VEGF ROS, p38 [14]
Fibroblast NHLF Short SWCNT CT 1 11 0.02–0.2 μg/cm2 C, TGF-β
ROS
[31]
Long SWCNT 13 11 (0.03–0.4 μg/ml) C, TGF-β
Fibroblast WI38-VA13 MWCNT SA 2.5–20 6–13 1–20 μg/ml cyt, TGF-β, PDGF ROS [13]
Fibroblast L929 MWCNT SA 5.5 10–300 μg/ml cyt ROS [32]
Macrophage THP-1 SWCNT NI 1–5 0.8–1.2 50 μg/ml IL-1β
IFM, ROS, End
[54]
MWCNT CT 10–30 20–30 IL-1β
Macrophage THP-1 SWCNT BSA-AP-Hipco NI 1000–5000 0.7–1.1 BSA coated 50–100 μg/ml IL-1β IFM [47]











Table 4 In vitro CNT activities on fibroblast, macrophage or epithelial cell (Continued)
SWCNT PF108-Hipco 500–1500 0.7-1.1 PF108 coated /
SWCNT BSA-AP-Arc 100–1000 1.2–2 BSA coated IL-1β nd
SWCNT BSA-PD-Arc 100–1000 1.2–2 BSA coated IL-1β nd
SWCNT PF108-Arc 100–1000 1.2–2 PF108 coated /
SWCNT BSA-PD-SG65 450–2000 0.7–1 BSA coated IL-1β nd
SWCNT PF108-SG65 450-2000 0.7–1 PF108 coated /
Macrophage THP-1 MWCNT BNR 67 2–10 μg/ml IL-1β IFM, ROCK, End [46]
Macrophage THP-1 AP MWCNT D CT BSA + DPPC 10–100 μg/ml IL-1β nd
AP MWCNT ND CT /
PD MWCNT D From AP 10–30 20–30 BSA + DPPC [36]
PD MWCNT ND From AP /
COOH MWCNT D From AP BSA + DPPC
COOH MWCNT ND From AP /
Macrophage PM, PBMC short MWCNT BMS 1–10 5–20 /
long tangled MWCNT CT 10–50 8–15 10–100 μg/ml / [43]
long needle-like MWCNT MC 13 >50 IL-1β, IL-α IFM, ROS, Src, Syc,
(Mitsui MWCNT-7) P2X7 R
Macrophage PAM raw MWCNT / IL-1β, IL-18 IFM
THP-1 pure MWCNT PD IL-1β, IL-18 IFM
raw MWCNT COOH NAM COOH F 25–100 μg/ml / [42]
pure MWCNT COOH COOH F - PD /
Macrophage PHM DWCNT PIH 0.1–100 1.2–3.2 25 μg/ml IL-1β, IL-18 IFM, End, K efflux [44]
Macrophage RAW 264.7 MWCNT SA 2.5–20 6–13 2–20 μg/ml IL-1β, TNF-α, IL-6, IL-10, MCP-1 NF-kB [13]
Macrophage THP-1, PBMC MWCNT HMS 0.5–40 10–30 Uncoated 10–100 μg/ml IL-1β, TNF-α, nd [50]
ALD-coated IL-6, OPN
IL-1β
Macrophage PAM Short MWCNT Nth 1.1 30 10 μg/ml / [58]
Long MWCNT 20 28 IL-6, IL-8 ROS
Macrophage THP-1 MWCNT AP CT 0.57 F IL-1β, TGF-β, PDGF











Table 4 In vitro CNT activities on fibroblast, macrophage or epithelial cell (Continued)
MWCNT sw-NH2 From AP 0.58 F IL-1β, TGF-β, PDGF
MWCNT PEI From AP 0.33 F 60 μg/ml IL-1β, TGF-β, PDGF for IL-1β: IFM, End [45]
MWCNT PEG From AP 0.27 F IL-1β, TGF-β
MWCNT cc-PEI From AP 0.38 F /
MWCNT COOH From AP /
Macrophage RAW 264.7 SWCNT CNI 1–4 100 μg/ml TGF-β nd [38]
Macrophage RAW 264.7 Short MWCNT NP 0.5–2 50 15 μg/ml / [15]
Long MWCNT 20–50 50 TGF-β, TNF-α nd
Macrophage NR8383 MWCNT HMS 0.3–50 10–30 10 μg/cm2 PDGF nd [51]
(16 μg/ml)
Epithelial cell A549 Short MWCNT SN 0.35–0.7 10–20 1–16 μg/cm2 / [65]
Long MWCNT 5–15 10–20 (1.6–25.6 μg/ml) EMT TGF-β/Smad
Epithelial cell RLE-6TN MWCNT NP 20–50 50 30 μg/ml EMT TGF-β/Smad [24]
Epithelial cell HBE MWCNT HMS 0.5–40 10–30 1.5–24 μg/ml IL-1β, IL-18 IFM, ROS [16]
IL-8
Epithelial cell BEAS-2B MWCNT BNR 67 1–10 μg/ml IL-6, IL-8, MIF NF-kB, p38, [71]
ERK 1/2, HSP27
Epithelial cell TT1, ATII MWCNT 0.6 μm Nth 1.1 30 IL-6, IL-8, MCP-1
MWCNT 3 μm 4.3 33 1–50 μg/ml IL-8, MCP-1 JNK, p38, ERK 1/2 [67]
MWCNT 20 μm 20 28 MCP-1
Epithelial cell BEAS-2B SWCNT BSA-AP-Hipco NI 1000–5000 0.7–1.1 BSA coated TGF-β
SWCNT BSA-PD-Hipco 500–1500 0.7–1.1 BSA coated TGF-β
SWCNT PF108-Hipco 500–1500 0.7–1.1 PF108 coated /
SWCNT BSA-AP-Arc 100–1000 1.2–2 BSA coated 100 μg/ml TGF-β nd [47]
SWCNT BSA-PD-Arc 100–1000 1.2–2 BSA coated TGF-β
SWCNT PF108-Arc 100–1000 1.2–2 PF108 coated TGF-β
SWCNT BSA-PD-SG65 450–2000 0.7–1 BSA coated TGF-β
SWCNT PF108-SG65 450–2000 0.7–1 PF108 coated /
Epithelial cell BEAS-2B AP MWCNT D CT 10–30 20–30 BSA + DPPC 10–100 μg/ml TGF-β [36]
AP MWCNT ND CT / /











Table 4 In vitro CNT activities on fibroblast, macrophage or epithelial cell (Continued)
PD MWCNT ND From AP / /
nd
COOH MWCNT D From AP BSA + DPPC Few TGF-β
COOH MWCNT ND From AP / Few TGF-β
Epithelial cell BEAS-2B MWCNT SA 2.5–20 6–13 2–200 μg/ml TGF-β, PDGF ROS [13]
nd: not determined. Cell name: A549: human lung adenocarcinoma alveolar epithelial cell line; ATII: primary human alveolar type-II epithelial cells; BALB-3 T3: mouse embryonic fibroblast cell line; BEAS-2B: human bronchial
epithelial cell line; CRL1490: human lung fibroblast cell line; HBE: primary human bronchial epithelial cells; HFL-1: human lung fibroblast cell line; L929: mouse fibroblast cell line; MLg: mouse lung fibroblast cell line; NHLF: normal
human lung fibroblast cell line; NIH-3 T3: mouse embryonic fibroblast cell line; NR8383: rat alveolar macrophage cell line; PAM: primary alveolar macrophages; PBMC: peripherial blood mononuclear cells; PHM: primary human
monocytes; PMF: primary mouse fibroblasts; RAW 264.7: mouse leukemic monocyte macrophage cell line; RLE-6TN: rat alveolar type II epithelial cell line; THP-1: human leukemia monocytic cell line; TT1: transformed human
alveolar type-I-like epithelial cells; WI38-VA13: human normal lung fibroblast cell line immortalized with SV40. CNT type: AP: as prepared; COOH: carboxyl; NH2: amino; PD: purified. Source: A: Arkema (France); BMS: Bayer Material
Science (Leverkusen, Germany); BNR: Bussan Nanotech Research (Ibaraki, Japan); CNI: Carbon Nanotechnologies Inc. (Houston, TX); CT: Cheap Tubes (Brattlebore, VT); HMS : Helix Materials Solution (Richardson, TX); MC: Mitsui &
Company (Tokio, Japan); N: Nanocyl (Sambreville, Belgium); NAM: Nanostructured & Amorphous Materials Inc. (Houston, TX); NI: NanoIntegris (Skokie, IL); NP: Nanotech Port (Chengdu, China); Nth: Nanothinx (Rio Patras, Greece);
PIH: produced in house; SA: Sigma-Aldrich (Lyon, France); SN: Shenzhen Nanoharbor (Shenzhen, China). Other: AD: acetone/sonication dispersed; BSA: bovine serum albumin; cc-PEI: carboxyl converted PEI; D: dispersed; DPPC:
dipalmitoylphosphatidylcholine; F: functionalized; ND: no dispersed; PEG: polyethylene glycol; PEI: polyethyleneimine; PF108: Pluronic F108; SD: survanta dispersed; swNH2: sidewall amine. Effects: C: collagen; cyt: cytotoxic;
D: differentiation of fibroblasts into myofibroblasts; EMT: epithelial mesenchymal transition; IL: interleukin; MCP: monocyte chemoattractant protein; MIF: migration inhibitory factor; MMP-9: matrix metallopeptidase 9;
OPN: osteopontin; P: proliferation; PDGF: platelet derived growth factor; TGF: transforming growth factor; TNF: tumor necrosis factor; VEGF: vascular endothelial growth factor. Mechanisms: End: endocytosis; ERK 1/2: extracellular











Signs of oxidative stress have also been observed in epi-
thelial cells and several studies reported free radical forma-
tion and antioxidant depletion in this cell system after
CNT exposure [60, 61, 72–74]. Interestingly, Nymark et al.
[75], observed the formation of a unique and yet unidenti-
fied radical in both absence and presence of BEAS-2B by
two types of long MWCNT (average of lengths 4 and
6 μm). However, contrary to macrophages, there is no evi-
dence of a correlation between oxidative stress and the re-
lease of pro-inflammatory mediators. Additional analysis
showed that early intracellular uptake of MWCNT (length
1–5 μm; 24 μg/cm2 corresponding to 38 μg/ml, consider-
ing a well surface area of 0.32 cm2) in BEAS-2B correlated
with the generation of ROS measured by DCF-DA [37].
Authors suggested that this can lead to different variations
in the cellular homeostasis, including cell proliferation, dif-
ferentiation and motility. SWCNT and MWCNT induced
epithelial cell proliferation [29, 34]. However it is still not
possible to determine whether this effect is related to
CNT-induced ROS and more studies have to be carried
out to understand the mechanisms. Moreover, Hussain et
al. [16] showed that CNT-induced ROS were also
associated to cytotoxic effects as these authors observed a
reduction of human bronchial epithelial death after anti-
oxidant treatment.
Regarding the indirect effect of CNT on fibroblasts via
epithelial cells, inflammasome, NF-κB and oxidative
stress appear as mechanisms altering signal transduction
pathways, as previously indicated for macrophages, by
inducing the release of different mediators able to acti-
vate fibroblasts.
Relevance of in vitro CNT activities for in vivo effects
As for macrophages, few studies investigated the correl-
ation between in vitro and in vivo results regarding the
development of fibrosis via epithelial cells. Two studies
observed a good correlation between the release of the
pro-fibrogenic TGF-β from BEAS-2B exposed to CNT
in vitro and the induction of a fibrotic response in vivo
[36, 47]. Moreover, CNT-induced EMT in vitro cor-
related with in vivo studies, suggesting that some
fibroblasts involved in the lung fibrosis originate from
epithelial cells. Further investigation is, however, re-
quired to understand the critical role of epithelial cells
in fibrosis.
For the AOP we identify the release of TGF-β from
epithelial cells as a key mediator of the indirect effect of
CNT on fibroblasts via epithelial cells. However, other
relevant mediators, PDGF, IL-1β and IL-8, and pathways,
such as inflammasome, NF-kB and oxidative stress, have
been shown in vitro to play a role in the complex fi-
brotic process. Collectively, these data are summarized
in Fig. 3.
Determinants of the fibrotic activities of CNT
Physico-chemical properties of CNT appear to deter-
mine their capacity to induce fibroblast, macrophages
and epithelial cell activation. The length has been
Fig. 4 AOP for CNT and lung fibrosis. Legend: Cp: collagen production; D: differentiation; P: proliferation; T: transition in fibroblasts
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identified as an important factor. Manke et al. [31]
showed that long SWCNT (13 μm) were more potent
than short SWCNT (1 μm) to elicit a ROS response, col-
lagen production and TGF-β release by fibroblasts in
vitro as well as to induce fibrosis in vivo. Several studies
confirmed that the length of CNT constitutes an import-
ant determinant in the capacity of these materials to in-
duce the activation of fibroblasts and lung fibrosis [24,
34]. Regarding macrophages, Wang et al. [15] showed
that only long MWCNT (0.6 mg/rat, corresponding to
3 mg/kg b.w.; length 20–50 μm and diameter 50 nm)
stimulated the release of TGF-β in vivo, as measured by
immunohistochemistry, contrary to short CNT (length
0.5-2 μm and diameter 50 nm). Long MWCNT (10 μg/
ml; length 20 μm), but not short fibers (length 0.6 μm),
were also shown to affect alveolar macrophage function,
including cell death, ROS generation and pro-
inflammatory (IL-6 and IL-8) mediator release [58]. A
stronger ROS generation was also observed in A549 epi-
thelial cells exposed to long CNT (length 5–30 μm;
doses 5–20 μg/ml) compared to short fiber (length 0.5–
2 μm) [76]. Poland et al. [3] reported frustrated phago-
cytosis in the peritoneal lavage of mice exposed to long
MWCNT (50 μg/mouse, corresponding to 2.5 mg/kg
b.w.), whereas short and tangled MWCNT were com-
pletely phagocytosed by macrophages. An accelerated
rate of clearance of short CNT by macrophages has been
reported, suggesting that these particles could be taken
up by inflammatory cells leading to their translocation
from the lung and, possibly, biodegradation, while long
CNT seem to be biopersistent [77, 78]. Long MWCNT
and SWCNT (length of 5–9 μm and 0.5–100 μm, re-
spectively) have been shown to cause an impairment of
airway epithelium barrier contrary to short particles.
However, short MWCNT (length 0.6 μm) were shown
to induce greater IL-6, IL-8 and MCP-1 levels than long
MWCNT (length 20 μm) in TT1 and ATII cells [67].
CNT diameter also appeared critical since CNT with a
thin diameter have been shown to stimulate fibroblast
proliferation and to induce fibrosis compared to CNT
with a thicker diameter [34].
The presence of residual metals from the synthesis of
CNT has been shown to be associated to oxidative
stress. Aldieri et al. [79] observed that only Fe-rich
MWCNT were significantly cytotoxic and genotoxic in
murine alveolar macrophages and induced a severe oxi-
dative stress, contrary to the Fe-free MWCNT, suggest-
ing that metals can be important factors in promoting
CNT-induced toxicity. These data were further con-
firmed in another study, in which two types of SWCNT
with different iron content, 26 wt. % and 0.23 wt. %
(0.12–0.5 mg/ml), generated different amount of hy-
droxyl radicals in RAW 264.7 macrophages, confirming
that iron can act as a catalyst of oxidative stress [80].
Finally, CNT dispersion was also found as another
critical factor. Several evidences show that well dispersed
CNT stimulate proliferation and collagen production by
lung fibroblasts [29, 30], induce the release of IL-1β
from macrophages [13, 35, 36, 43–47] and TGF-β from
epithelial cells [36, 47], compared to not dispersed CNT.
The extent and localization of CNT and inflammatory
cells in the lung was also related to the particle disper-
sion and agglomeration state before administration. Ag-
glomerated CNT form granulomatous inflammation and
fibrosis in larger airways, while, in general, well-
dispersed CNT are able to penetrate alveoli and intersti-
tial space leading to alveolar fibrosis, as discussed in the
section on fibroblasts [15, 28, 29, 81].
Conclusion
The observations summarized in this review highlight
indirect and direct effects of CNT on fibroblasts, which
both contribute to their fibrogenic activity on the lung.
In vitro studies indicate that a dose range of CNT be-
tween 1 and 100 μg/ml induced effects on the different
cell types, as shown in Table 4, which summarizes in
vitro data reported in this review. The dose range used
in in vivo experiments (10–100 μg/mouse, corresponding
to 0.5–5 mg/kg) is relevant for human exposure scenari,
following the approach suggested by Porter et al. [82], and
shown to exert a fibrotic activity in the lung of experimen-
tal animals. We propose in Fig. 4 a linear flow diagram
based on an AOP structure describing the processes by
which CNT have been shown to lead to fibroblast activa-
tion and pulmonary fibrosis. Physico-chemical properties
of CNT, such as length and diameter are relevant for their
fibrogenic activity. Therefore, an accurate analysis of these
characteristics can already suggest whether a material may
have or not a pro-fibrotic activity. The exact macro-
molecular interactions (MMI) between CNT and cells
have currently not been identified and we can only
hypothesize that this probably occurs at the surface of
membranes in fibroblasts, macrophages and epithelial
cells. CNT have been observed to induce several cellular
responses, which can be stratified according to 5 levels: i)
initial signaling, ii) pro-inflammatory mediators, iii) pro-
fibrotic mediators, iv) distal signaling in response to
mediators and finally v) activation of key cells in fibrosis
(fibroblasts and epithelial cells for EMT). ROS, MAPK,
NF-kB, NADPH oxidase and inflammasome have been
identified as the most important initial signals, with some
differences depending on the cell type. Only macrophages
and epithelial cells have been observed to release pro-
inflammatory mediators with pro-fibrotic activities (IL-1β,
IL-18, IL-8 and TNF-α) upon exposure to CNT. IL-1β
seems to play a major role by promoting the secretion of
pro-fibrotic mediators. PDGF and TGF-β can also be re-
leased directly from fibroblasts, macrophages or epithelial
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cells after CNT exposure and have been shown to activate
the second signaling (ERK1/2 and Smad). Additionally,
CNT prolonge ERK 1/2 activation in fibroblasts exposed
to PDGF. ERK 1/2 and Smad phosphorylation was also
prolonged by CNT in presence of TGF-β. ERK 1/2 and
Smad signalings stimulated fibroblast proliferation, while
Smad can also increase fibroblast differentiation, promote
EMT and increase collagen production. This sequence of
key events eventually causes collagen accumulation and
ECM alteration and leads to the development of lung
fibrosis.
These data will be useful to guide researchers to focus
on relevant mechanisms of action induced by CNT, or
to investigate underlined knowledge gaps. The proposed
AOP can help proposing or developing simple and fast
test methods for predicting the potential hazard of CNT.
Most importantly, it will help identifying how a mechan-
istic information obtained from one specific assay con-
tributes to obtaining a global picture of the fibrogenic
activity of a test sample.
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